Literature DB >> 14647067

Dexamethasone inhibits early regenerative response of rat liver after cold preservation and transplantation.

Fotini Debonera1, Alyssa M Krasinkas, Andrew E Gelman, Xavier Aldeguer, Xingye Que, Abraham Shaked, Kim M Olthoff.   

Abstract

Regeneration is crucial for the recovery of hepatic mass following liver transplantation. Glucocorticoids, immunosuppressive and antiinflammatory agents commonly used in transplantation, are known to inhibit the expression of specific cytokines and growth factors. Some of these proteins, namely tumor necrosis factor alpha (TNF-alpha) and interleukin 6 (IL-6), play a critical role in the initiation of liver regeneration. Following cold preservation and reperfusion of the transplanted liver, the normal recovery process is marked by increased expression of TNF-alpha and IL-6, followed by activation of cytokine-responsive transcription factors and progression of the cell cycle resulting in hepatocyte proliferation. We hypothesized that glucocorticoids may influence the repair mechanisms initiated after extended cold preservation and transplantation. Using a rat orthotopic liver transplant model, recipient animals were treated with dexamethasone at the time of transplantation of liver grafts with prolonged cold storage (16 hours). Treatment with dexamethasone suppressed and delayed the expression of TNF-alpha and IL-6 compared with animals receiving no treatment and attenuated downstream nuclear factor kappaB (NF-kappaB), signal transduction and activator of transcription 3 (STAT3), and activation protein 1 (AP-1) activation. This suppression was accompanied by poor cell-cycle progression, delayed cyclin D1 nuclear transposition, and impaired hepatocyte proliferation by BrdU uptake. Histologically, the liver grafts in treated animals demonstrated more injury than controls, which appeared to be necrosis, rather than apoptosis. In conclusion, these data provide evidence that the administration of glucocorticoids at the time of transplantation inhibits the initiation of the regenerative process and may have a deleterious effect on the recovery of liver grafts requiring significant regeneration. This may be particularly relevant for transplantation of partial liver grafts in the living donor setting.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14647067     DOI: 10.1016/j.hep.2003.09.036

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

1.  Low-dose steroid pretreatment ameliorates the transient impairment of liver regeneration.

Authors:  Toshihito Shibata; Toru Mizuguchi; Yukio Nakamura; Masaki Kawamoto; Makoto Meguro; Shigenori Ota; Koichi Hirata; Hidekazu Ooe; Toshihiro Mitaka
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

2.  Early post-operative measurement of cytokine plasma levels combined with pre-operative bilirubin levels identify high-risk patients after liver resection.

Authors:  Christoph W Strey; Rosa Maria Marquez-Pinilla; Maciej M Markiewski; Britta Siegmund; Elsie Oppermann; John D Lambris; Wolf O Bechstein
Journal:  Int J Mol Med       Date:  2010-12-28       Impact factor: 4.101

3.  Metabonomic Profile of Macrosteatotic Allografts for Orthotopic Liver Transplantation in Patients With Initial Poor Function: Mechanistic Investigation and Prognostic Prediction.

Authors:  Zhengtao Liu; Hai Zhu; Wenchao Wang; Jun Xu; Shuping Que; Li Zhuang; Junjie Qian; Shuai Wang; Jian Yu; Feng Zhang; Shengyong Yin; Haiyang Xie; Lin Zhou; Lei Geng; Shusen Zheng
Journal:  Front Cell Dev Biol       Date:  2020-08-28

Review 4.  Genomics of liver transplant injury and regeneration.

Authors:  Sohaib Khalid Hashmi; Esther Baranov; Ana Gonzalez; Kim Olthoff; Abraham Shaked
Journal:  Transplant Rev (Orlando)       Date:  2014-03-04       Impact factor: 3.943

5.  Adult-adult living donor liver transplantation.

Authors:  Masatoshi Makuuchi; Charles M Miller; Kim Olthoff; Myron Schwartz
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

6.  Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation.

Authors:  A Shaked; R M Ghobrial; R M Merion; T H Shearon; J C Emond; J H Fair; R A Fisher; L M Kulik; T L Pruett; N A Terrault
Journal:  Am J Transplant       Date:  2008-12-15       Impact factor: 8.086

7.  Partial Inhibition of HO-1 Attenuates HMP-Induced Hepatic Regeneration against Liver Injury in Rats.

Authors:  Ning He; Jun-Jun Jia; Hai-Yang Xie; Jian-Hui Li; Yong He; Sheng-Yong Yin; Ruo-Peng Liang; Li Jiang; Jing-Feng Liu; Kang-di Xu; Zhi-Hao Zhang; Lin Zhou; Shu-Sen Zheng
Journal:  Oxid Med Cell Longev       Date:  2018-04-15       Impact factor: 6.543

8.  De Novo Donor-Specific HLA Antibody Formation in Two Patients With Crigler-Najjar Syndrome Type I Following Human Hepatocyte Transplantation With Partial Hepatectomy Preconditioning.

Authors:  C Jorns; G Nowak; A Nemeth; H Zemack; L-M Mörk; H Johansson; R Gramignoli; M Watanabe; A Karadagi; M Alheim; D Hauzenberger; R van Dijk; P J Bosma; F Ebbesen; A Szakos; B Fischler; S Strom; E Ellis; B-G Ericzon
Journal:  Am J Transplant       Date:  2015-11-02       Impact factor: 8.086

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.